RT Journal Article
SR Electronic
T1 Understanding frailty: probabilistic causality between components and their relationship with death through a Bayesian network and evidence propagation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.02.22271711
DO 10.1101/2022.03.02.22271711
A1 Ramírez-Aldana, Ricardo
A1 Parra-Rodríguez, Lorena
A1 Gomez-Verjan, Juan Carlos
A1 Garcia-Peña, Carmen
A1 Gutierrez-Robledo, Luis Miguel
YR 2022
UL http://medrxiv.org/content/early/2022/03/09/2022.03.02.22271711.abstract
AB Identifying relationships between components of an index helps to have a better understanding of the condition they define. The Frailty Index (FI) measures the global health of individuals and can be used to predict outcomes as mortality. Previously, we modelled the relationship between the FI components (deficits) and death through an undirected graphical model, analyzing their relevance from a social network analysis framework. Here, we model the FI components and death through an averaged Bayesian network obtained through a structural learning process and resampling, to understand how the FI components and death are causally related. We identified that the components are not similarly related between them and that deficits are related according to its type. Two deficits were the most relevant in terms of their connections and other two were directly associated with death. We also obtained the strength of the relationships to identify the most plausible, identifying clusters of deficits heavily related. Finally, we propagated evidence (assigned values to all deficits) and studied how FI components predict mortality, obtaining a correct assignation of almost 74%, whereas a sensitivity of 56%. As a classifier of death, the more number of deficits included for the evidence, the best performance; but the FI seems not to be very good to correctly classify death people.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves available human data, whose access is granted after registration. These data are part of the Mexican Health and Aging Study (MHAS), whose datasets are available at http://mhasweb.org/Data.aspx The owners of this information declare that the MHAS study protocol and instruments were approved by the Institutional Review Board or Ethics Committee of the University of Texas Medical Branch, the INEGI in Mexico, and the Instituto Nacional de Salud Publica (INSP) in Mexico. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are available online at http://mhasweb.org/Data.aspx The derivation of each variable is explained in the Supplementary material